Burkavage Brian
SEC insider (Form 3/4/5 filer). CIK 0001865633. SVP, Finance at Damora Therapeutics, Inc. (DMRA) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 2, 2025. Located in WALTHAM, MA.
Companies Burkavage Brian has filed insider reports for
- Damora Therapeutics, Inc. (DMRA): Officer, SVP, Finance
- IO Biotech, Inc. (IOBT): Officer, Chief Accounting Officer
Burkavage Brian
CIK: 0001865633
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
